Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 9805
MIM: 614965
HGNC: 22192
Ensembl: ENSG00000136193
Variants:
dbSNP: 9805
ClinVar: 9805
TCGA: ENSG00000136193
COSMIC: SCRN1
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36946611 | 2023 | SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease. | 1 |
| 37691034 | 2023 | Knockdown of Secernin 1 inhibit cell invasion and migration by activating the TGF-β/Smad3 pathway in oral squamous cell carcinomas. | 0 |
| 36946611 | 2023 | SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease. | 1 |
| 37691034 | 2023 | Knockdown of Secernin 1 inhibit cell invasion and migration by activating the TGF-β/Smad3 pathway in oral squamous cell carcinomas. | 0 |
| 31796108 | 2019 | Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies. | 15 |
| 31796108 | 2019 | Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies. | 15 |
| 26883194 | 2016 | Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation. | 5 |
| 26883194 | 2016 | Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation. | 5 |
| 25399950 | 2014 | A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancer. | 12 |
| 25399950 | 2014 | A genetic variant of miR-148a binding site in the SCRN1 3'-UTR is associated with susceptibility and prognosis of gastric cancer. | 12 |
| 22360420 | 2012 | Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration. | 24 |
| 22360420 | 2012 | Proteomic analysis identifies dysfunction in cellular transport, energy, and protein metabolism in different brain regions of atypical frontotemporal lobar degeneration. | 24 |
| 21385630 | 2011 | Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. | 13 |
| 21385630 | 2011 | Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. | 13 |
| 20039278 | 2010 | SCRN1 is a novel marker for prognosis in colorectal cancer. | 16 |
Citation
Dessen P
SCRN1 (secernin 1)
Atlas Genet Cytogenet Oncol Haematol. 2010-05-01
Online version: http://atlasgeneticsoncology.org/gene/51454/scrn1
